Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE Vernova Inc (GEV) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

GE Vernova IncTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

GE Vernova Inc vs Intuitive Surgical, Inc. — how do they compare? GE Vernova Inc trades at $1,027.56 (market cap $283.57B), while Intuitive Surgical, Inc. trades at $400.14 (market cap $137.76B). The key difference: GE Vernova Inc is far larger — about 2.1× Intuitive Surgical, Inc.'s market cap, and GE Vernova Inc pays a 0.19% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.

GEVISRG
Market Cap
$283.57B$137.76B
Sector
TechnologyHealth
52-Week High
$1.17K$592.85
52-Week Low
$547.96$379.50
Enterprise Value
$276.21B$133.24B
Dividend Yield
0.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE Vernova Inc

GE Vernova (GEV) trades at $1,038, down 2.63% today, with mixed technical signals showing bearish overall momentum but bullish moving averages. The company demonstrates strong profitability with 23.81% net income margin and 83.23% ROE, though valuation metrics appear elevated with P/E of 30.84 and EV/EBITDA of 109.82. Recent earnings showed volatility with Q1 2026 beating expectations by a wide margin, while the company prepares for Q2 2026 results amid significant AI-driven power demand growth.

The outlook remains positive with analyst consensus strongly bullish (21 buy ratings, 0 sell) and $1,260 price target representing 21% upside. Key opportunities include AI data center power demand and $11 billion investment push, while risks include wind segment pressures and elevated valuation multiples that may limit near-term upside potential despite strong fundamentals.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $379.50, down 6.78% amid broader market pressure, yet maintains strong fundamentals with 28.15% net margins and consistent earnings beats. The stock faces technical headwinds with bearish moving averages but shows oversold RSI conditions. Recent news highlights competitive pressures but also strong da Vinci 5 adoption and upcoming Q2 earnings on July 16, where analysts expect another beat. Revenue growth remains robust at $10.06B for 2025, up from $8.4B in 2024.

Despite near-term volatility, ISRG's leadership in robotic surgery and analyst consensus price target of $552.36 suggest significant upside. Key risks include intensifying global competition and margin pressures, but the company's innovation pipeline and expanding procedure volumes support long-term growth. Institutional sentiment remains positive with 69.6% buy ratings, positioning ISRG as a compelling recovery candidate post-earnings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GE Vernova Inc

GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.

Read more on GEV

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG